Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-21-022666
Filing Date
2021-04-23
Accepted
2021-04-23 12:02:06
Documents
73
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2020_bostontherapeutics.htm 10-K 969397
2 CERTIFICATION f10k2020ex31-1_bostontherap.htm EX-31.1 11078
3 CERTIFICATION f10k2020ex31-2_bostontherap.htm EX-31.2 9257
4 CERTIFICATION f10k2020ex32-1_bostontherap.htm EX-32.1 4345
5 CERTIFICATION f10k2020ex32-2_bostontherap.htm EX-32.2 4339
  Complete submission text file 0001213900-21-022666.txt   5378281

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE bthe-20201231.xml EX-101.INS 685895
7 XBRL SCHEMA FILE bthe-20201231.xsd EX-101.SCH 71689
8 XBRL CALCULATION FILE bthe-20201231_cal.xml EX-101.CAL 31748
9 XBRL DEFINITION FILE bthe-20201231_def.xml EX-101.DEF 335771
10 XBRL LABEL FILE bthe-20201231_lab.xml EX-101.LAB 626218
11 XBRL PRESENTATION FILE bthe-20201231_pre.xml EX-101.PRE 348350
Mailing Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843
Business Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843 (603) 935-9799
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

EIN.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54586 | Film No.: 21848050
SIC: 2834 Pharmaceutical Preparations